139 related articles for article (PubMed ID: 34149231)
1. Histomorphological and Morphometric Evaluation of Microvessel Density in Nodal Non-Hodgkin Lymphoma Using CD34 and CD105.
; Kataria SP; Malik S; Yadav R; Kapil R; Sen R
J Lab Physicians; 2021 Mar; 13(1):22-28. PubMed ID: 34149231
[No Abstract] [Full Text] [Related]
2. Study of angiogenesis in invasive breast carcinoma by morphometry and immunohistochemistry.
Bhatia JK; Chaudhary T; Boruah D; Bharadwaj R
Med J Armed Forces India; 2022 Jul; 78(3):345-354. PubMed ID: 35855704
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma.
Mazur G; Wróbel T; Dziegiel P; Jeleń M; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2004; 42(4):241-3. PubMed ID: 15704651
[TBL] [Abstract][Full Text] [Related]
4. Histopathological Evaluation of Angiogenic Markers in Non-Hodgkin's Lymphoma.
Singh P; Tahlan A; Mohan H; Singh R
J Lab Physicians; 2023 Jun; 15(2):282-288. PubMed ID: 37323605
[No Abstract] [Full Text] [Related]
5. Angiogenesis in Non-Hodgkin's Lymphoma: An Intercategory Comparison of Microvessel Density.
Aggarwal D; Srivastava G; Gupta R; Pant L; Krishan G; Singh S
ISRN Hematol; 2012; 2012():943089. PubMed ID: 22536524
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
[TBL] [Abstract][Full Text] [Related]
7. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
8. Endoglin Expression and Microvessel Density as Prognostic Factors in Pediatric Rhabdomyosarcoma.
Radzikowska J; Krzeski A; Czarnecka AM; Klepacka T; Rychlowska-Pruszynska M; Raciborska A; Dembowska-Baginska B; Pronicki M; Kukwa A; Sierdzinski J; Kukwa W
J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33535525
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and comparison of microvessel density using the markers CD34 and CD105 in regenerative nodules, dysplastic nodules and hepatocellular carcinoma.
Segatelli V; de Oliveira EC; Boin IF; Ataide EC; Escanhoela CA
Hepatol Int; 2014 Apr; 8(2):260-5. PubMed ID: 26202507
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of microvessel density quantified through the immunohistochemistry expression of CD34 and CD105 in rectal cancer.
Goldiş DS; Sferdian MF; Tarţă C; Fulger LO; Totolici BD; Neamţu C
Rom J Morphol Embryol; 2015; 56(2):419-24. PubMed ID: 26193208
[TBL] [Abstract][Full Text] [Related]
11. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
12. [Expression of CD31, CD34 and CD105 in squamous cell carcinoma of tongue and their relationships with lymph node metastasis].
Zhang YY; Sun CF; Peng J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2008 Apr; 26(2):201-5. PubMed ID: 18605466
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.
Guo J; Higashi K; Ueda Y; Oguchi M; Takegami T; Toga H; Sakuma T; Yokota H; Katsuda S; Tonami H; Yamamoto I
J Nucl Med; 2006 Mar; 47(3):419-25. PubMed ID: 16513610
[TBL] [Abstract][Full Text] [Related]
14. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
15. Morphometric angiogenesis parameters for indolent and aggressive non-Hodgkin's lymphoma.
Kopic E; Cickusic E; Kopic A; Arnautovic-Custovic A; Halilbasic A; Tinjic L; Hasic S; Simendic V
Med Arh; 2011; 65(1):9-12. PubMed ID: 21534443
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Microvessel Density Using Nestin and CD34 in Colorectal Cancer.
Chabowski M; Nowak A; Grzegrzolka J; Piotrowska A; Janczak D; Dziegiel P
Anticancer Res; 2018 Jul; 38(7):3889-3895. PubMed ID: 29970509
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Angiogenesis by Using CD105 and CD34 in Sudanese Breast Cancer Patients.
M Abbas A; Shalabi MG; A Elsiddig S; Eltahir Z; M A Babker A; G Ahmed H
Pak J Biol Sci; 2021 Jan; 24(11):1144-1151. PubMed ID: 34842386
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma].
Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
Przegl Lek; 2012; 69(10):726-30. PubMed ID: 23421020
[TBL] [Abstract][Full Text] [Related]
20. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
